The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis

Katrina M Morgan; Elissa Abou Khalil; Erin V Feeney; Philip C Spinella; Amelia C Lucisano; Barbara A Gaines; Christine M Leeper

doi:10.1097/CCM.0000000000006244

The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis

Crit Care Med. 2024 Mar 14. doi: 10.1097/CCM.0000000000006244. Online ahead of print.

Authors

Katrina M Morgan¹, Elissa Abou Khalil², Erin V Feeney¹, Philip C Spinella¹, Amelia C Lucisano¹, Barbara A Gaines³, Christine M Leeper¹

Affiliations

¹ Department of Surgery and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
² Department of Surgery, Northwestern University, Chicago, IL.
³ Department of Surgery, Division of Pediatric Surgery, University of Texas Southwestern Medical Center, Dallas, TX.

PMID: 38483205
DOI: 10.1097/CCM.0000000000006244

Abstract

Objectives: To assess if transfusion with low-titer group O whole blood (LTOWB) is associated with improved early and/or late survival compared with component blood product therapy (CT) in bleeding trauma patients.

Data sources: A systematic search of PubMed, CINAHL, and Web of Science was performed from their inception through December 1, 2023. Key terms included injury, hemorrhage, bleeding, blood transfusion, and whole blood.

Study selection: All studies comparing outcomes in injured civilian adults and children who received LTOWB versus CT were included.

Data extraction: Data including author, publication year, sample size, total blood volumes, and clinical outcomes were extracted from each article and reported following the Meta-analysis Of Observational Studies in Epidemiology guidelines. Main outcomes were 24-hour (early) and combined 28-day, 30-day, and in-hospital (late) mortality rates between recipients of LTOWB versus CT, which were pooled using random-effects models.

Data synthesis: Of 1297 studies reviewed, 24 were appropriate for analysis. Total subjects numbered 58,717 of whom 5,164 received LTOWB. Eleven studies included adults-only, seven included both adults and adolescents, and six only included children. The median (interquartile range) age for patients who received LTOWB and CT was 35 years (24-39) and 35.5 years (23-39), respectively. Overall, 14 studies reported early mortality and 22 studies reported late mortality. LTOWB was associated with improved 24-hour survival (risk ratios [RRs] [95% CI] = 1.07 [1.03-1.12]) and late (RR [95% CI] = 1.05 [1.01-1.09]) survival compared with component therapy. There was no evidence of small study bias and all studies were graded as a moderate level of bias.

Conclusions: These data suggest hemostatic resuscitation with LTOWB compared with CT improves early and late survival outcomes in bleeding civilian trauma patients. The majority of subjects were injured adults; multicenter randomized controlled studies in injured adults and children are underway to confirm these findings.